Rancho BioSciences Appoints Chris O'Brien as CEO to Deliver AI-Ready Data Solutions for Faster, More Reliable R&D
25.3.2026 13:00:00 CET | ACCESS Newswire | Press Release
Veteran life sciences leader to drive enterprise growth and expand adoption of AI-ready data solutions across pharma and biotech
SAN DIEGO, CA / ACCESS Newswire / March 25, 2026 / Rancho BioSciences today announced the appointment of Chris O'Brien as Chief Executive Officer. O'Brien will lead the company's next phase of growth as Rancho expands adoption of its AI-ready data solutions across pharmaceutical, biotechnology, and research organizations.
Rancho BioSciences delivers AI-ready data solutions that transform fragmented biomedical data into standardized, reusable assets for AI, analytics, and machine learning. As life sciences organizations continue investing in AI and advanced analytics, preparing inconsistent and siloed data remains a major bottleneck-often slowing analysis and limiting reuse across programs. Rancho addresses this by standardizing and harmonizing complex data so it can be used immediately and consistently across the R&D lifecycle.
O'Brien brings more than 20 years of leadership experience building and scaling organizations across the life sciences and research services ecosystem. Most recently, he served as Chief Executive Officer of Biorasi, where he led global clinical research operations supporting emerging biotech and pharmaceutical companies. Earlier, he served as President and Chief Operating Officer of Decision Resources Group and founded Linchpin Partnerships, advising organizations on growth strategy and strategic partnerships. He holds an MBA from the Tuck School of Business at Dartmouth and a BA from Middlebury College.
As CEO, O'Brien will focus on accelerating the expansion of Rancho's portfolio of data and AI-enabled solutions, strengthening operational rigor across the organization, and driving growth across enterprise accounts. A key priority will be scaling Rancho's platform capabilities to support larger, more strategic engagements, while improving efficiency, predictability, and speed across both the commercial and delivery lifecycle.
"Chris brings the leadership and operational experience we need to grow Rancho's impact in a rapidly evolving market," said Julie Bryant, founder and Chief Strategy Officer of Rancho BioSciences. "Our clients are no longer asking for one-off data projects-they need AI data strategy and execution partners who can deliver repeatable, future-proof solutions that can be applied across programs and therapeutic areas. Chris understands how to scale that kind of delivery while maintaining the scientific rigor our clients expect."
"I'm excited to join Rancho Biosciences at this pivotal moment," said Chris O'Brien. "The increasing complexity and volume of scientific data and the rapid adoption of AI create a clear need for trusted partners who can deliver structured, high-quality data and actionable insights at enterprise scale. Julie Bryant and Rancho have built a strong foundation, and I look forward to working with the team to expand our impact, deepen client partnerships, drive sustained growth and help bring life-saving medicines to patients in need."
"Chris brings the leadership and execution focus required to scale Rancho into its next phase," said Ray Hill, Operating Partner at Arsenal Capital Partners. "His experience building high-performing teams and driving commercial discipline, combined with a deep understanding of the life sciences R&D ecosystem, will be instrumental in advancing Rancho's growth strategy and delivering long-term value to clients."
Chris's appointment reinforces Rancho's strategic focus on building a scaled, science-led data and AI platform that enables life sciences organizations to improve decision-making and increase R&D productivity. The company will continue to invest in its core capabilities, data assets, and strategic alliances to support long-term, durable growth.
About Rancho BioSciences
Rancho BioSciences delivers AI-ready data solutions that enable life sciences organizations to standardize, integrate, and reuse complex biomedical data across the R&D lifecycle. With more than 150 scientists, data engineers, and bioinformatics specialists, Rancho supports faster, more reliable analytics and AI-driven decision-making across discovery, translational research, and clinical development. The company's expertise spans data engineering, scientific curation, bioinformatics, data science, and strategic data initiatives. Rancho is driven by its mission of Saving Lives Through Data.
Contact Information
Jonathan Amir (VP, Marketing): jonathan.amir@ranchobiosciences.com
SOURCE: Rancho BioSciences, LLC
View the original press release on ACCESS Newswire
Rancho BioSciences, LLC
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI Further Expands IP Portfolio with New Patent Issuance and Notices of Allowance22.4.2026 16:00:00 CEST | Press Release
Builds on December 2025 Content Licensing Patents and Carbon Credit Tokenization Grant; Strengthens IP Moat Across Data Valuation, Virtual Funding, and Tokenized Tax Prep PHILADELPHIA, PA / ACCESS Newswire / April 22, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a leader in AI-driven data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, today announced the issuance of U.S. Patent No. 12,596,819 and Notices of Allowance on two additional U.S. patent applications. This milestone builds directly on the Company's December 2025 issuance of two foundational patents for blockchain-driven content licensing and tokenized monetization - further expanding its robust intellectual property portfolio headlined by the industry-defining Carbon Credit Tokenization Patent. Key Highlights for Investors One newly issued patent and two Notices of Allowance extend protection across three high-value platforms: AI-validated d
Karbon-X Highlights SkyXero on Earth Day, Bringing Real-Time Climate Action to Travel22.4.2026 15:15:00 CEST | Press Release
Company underscores leadership use and introduces matched contribution initiative to support verified climate projects. CALGARY, AB / ACCESS Newswire / April 22, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions provider operating across compliance and voluntary carbon markets, today marked Earth Day by highlighting SkyXero, its mobile application designed to help individuals understand and act on the emissions associated with their air travel. As global travel continues to increase, flight emissions remain one of the least visible and least understood components of individual environmental impact. SkyXero addresses this gap by enabling users to calculate emissions associated with any commercial flight and support verified climate projects such as reforestation, renewable energy, and carbon reduction initiatives. To reinforce its commitment to practical climate accountability, Karbon-X has applied SkyXero internally across its l
DOJO AI Raises $6M to Power Agentic Marketing Platform, Transforming Data Into Business Impact22.4.2026 14:00:00 CEST | Press Release
Backed by Armilar and Heartfelt VC, the company serves over 100 customers across the U.S. and U.K., including CoinDesk, Morningstar, Broadvoice, PensionBee, CovertSwarm and Refine Labs LONDON, UK AND LISBON, PORTUGAL / ACCESS Newswire / April 22, 2026 / DOJO AI, the intelligent marketing system that brings a new class of integrated AI to marketing teams, today announced a $6 million seed round at a $30 million valuation. The round was led by Armilar, with participation from Heartfelt VC. The funding will support continued product development and accelerated expansion in the United States. DOJO AI introduces a new paradigm for marketing technology, powering what the industry is beginning to call agentic marketing: a system where AI agents don't just report on performance but take action on it. The platform watches paid and organic campaigns around the clock, audits SEO and Answer Engine Optimization visibility continuously, generates brand-aligned content, and feeds every outcome back i
GoodData Launches Agent Builder for Enterprise AI22.4.2026 12:00:00 CEST | Press Release
Enterprises can now deploy governed analytics agents in minutes, with full control over configuration, context, and scale. SAN FRANCISCO, CA / ACCESS Newswire / April 22, 2026 / GoodData, the AI-powered analytics and decision intelligence platform, today announced the launch of Agent Builder, a new capability that expands its platform with a dedicated environment for building, configuring, and scaling AI agents across the enterprise. Agent Builder enables organizations to move beyond single-purpose AI assistants and instead deploy multiple, purpose-built analytics agents that can be precisely configured, governed, and scaled across customers, workspaces, and user groups. The launch addresses a growing enterprise challenge: while organizations are rapidly moving from experimentation to production with AI agents, consistent, secure, and scalable deployment across business units remains difficult without significant custom engineering. From Experimentation to Enterprise Scale While most a
Karbon-X Reports $60.8 Million in Nine-Month Revenue and Files Q3 Form 10-Q21.4.2026 17:40:00 CEST | Press Release
CALGARY, AB / ACCESS Newswire / April 21, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the nine months ended February 28, 2026. The filing reflects Karbon-X's continued expansion in global carbon markets, with year-to-date revenue of $60.8 million, a strengthened balance sheet, and a growing project pipeline, supported by increasing demand for high-integrity carbon solutions. "Karbon-X has scaled significantly over the past twelve months, with nine-month revenue of $60.8 million reflecting strong commercial execution across our trading operations," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "While Q3 trading volumes reflected expected variability in settlement timing across international markets, our underlying business continues to strengthen. We remain focused on disciplined growth across trading, project development, and dig
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom